Hyperthyroidism produces a characteristic constellation of adrenergic symptoms — palpitations, tachycardia, and tremor — that require targeted management. Controlling these manifestations is a primary clinical priority regardless of the underlying cause of the thyroid excess.
Control of the adrenergic symptoms: palpitations, tachycardia, and tremor.
Beta-blocker therapy is the cornerstone of adrenergic symptom management in hyperthyroidism.
The full protocol specifies the agents within this class, clinical selection criteria, and relevant considerations — available via the link below.
Regardless of the cause of hyperthyroidism, the adrenergic symptoms are controlled by beta blockers (Table 5).